Starling Oncology STLN
$3.62 −$3.08 (-45.97%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $3.63 +0.28%
Open$6.06
Prev close$6.70
Day range$3.35 – $6.43
Volume23.92M
Market cap$369.21M
P/E (TTM)–
Dividend yield–
STLN Stock News
Headlines matching Starling Oncology or the STLN ticker, most recent first.
- B. Riley Securities Initiates Starling Oncology(STLN.US) With Buy Rating, Announces Target Price $11
- Needham Maintains Starling Oncology(STLN.US) With Buy Rating, Maintains Target Price $7
- Needham Initiates Starling Oncology(STLN.US) With Buy Rating, Announces Target Price $7
- The Oncology Institute: The Oncology Institute, Inc. - Name/Symbol Change Option Symbol: TOI New Symbol: STLN
- Needham Maintains Starling Oncology(STLN.US) With Buy Rating, Raises Target Price to $9 Positive
- Analysts Offer Insights on Healthcare Companies: Starling Oncology Institute (STLN), Axsome Therapeutics (AXSM) and Contineum Therapeutics, Inc. Class A (CTNM)
No comments yet — be the first to weigh in on STLN.